Gastrointestinal Metabolism Laboratory and Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
J Clin Endocrinol Metab. 2011 Oct;96(10):E1630-3. doi: 10.1210/jc.2011-1130. Epub 2011 Aug 10.
The use of Roux-en-Y gastric bypass (RYGB) surgery to treat severe obesity has grown dramatically. RYGB is highly effective, but the response in individual patients varies widely, and clinical predictors have been able to explain only a fraction of this variation.
Our objective was to determine whether there is a significant genetic contribution to weight loss after RYGB.
We genotyped 848 patients undergoing RYGB. Using identity-by-descent methods, we identified 13 pairs of first-degree relatives. We identified an additional 10 pairs of individuals who were living together but are not genetically related and randomly paired the remaining 794 individuals. We then compared weight loss within and across pairs.
First-degree relative pairs had a similar response to surgery, with a 9% mean difference in excess weight loss between members of each pair. This similarity was not seen with cohabitating individuals (26% mean difference; P = 0.005 vs. first-degree pairs) or unrelated individuals (25% mean difference; P = 0.001). Cohabitating individuals had within-pair differences in weight loss no more similar than randomly paired individuals (P = 0.60). The pair relationship explained a significant portion of the variation in weight loss in first-degree relatives [intraclass correlation coefficient (ICC) = 70.4%; P = 0.02] but not in random subjects (ICC = 0.9%; P = 0.48) or genetically unrelated cohabitating individuals (ICC = 14.3%; P = 0.67).
Genetic factors strongly influence the effect of RYGB on body weight. Identification of the specific genes that mediate this effect will advance our understanding of the biological mechanisms of weight loss after RYGB and should help identify patients who will benefit the most from this intervention.
Roux-en-Y 胃旁路(RYGB)手术治疗严重肥胖症的应用显著增加。RYGB 非常有效,但个体患者的反应差异很大,临床预测因素只能解释这种变化的一小部分。
我们旨在确定 RYGB 后体重减轻是否存在显著的遗传贡献。
我们对 848 例接受 RYGB 的患者进行了基因分型。使用血缘关系方法,我们确定了 13 对一级亲属。我们还确定了另外 10 对共同生活但没有遗传关系的个体,并将其余 794 例个体随机配对。然后,我们比较了每对个体内和个体间的体重减轻情况。
一级亲属对手术的反应相似,每对成员之间的超重减轻量平均差异为 9%。这与共同生活的个体(平均差异为 26%;P=0.005 与一级亲属对比较)或无血缘关系的个体(平均差异为 25%;P=0.001)之间未见相似性。共同生活的个体之间的体重减轻差异并不比随机配对的个体更相似(P=0.60)。亲属关系解释了一级亲属体重减轻的很大一部分变异(组内相关系数 [ICC] =70.4%;P=0.02),但在随机对象中(ICC=0.9%;P=0.48)或无血缘关系的共同生活个体中(ICC=14.3%;P=0.67)则没有解释。
遗传因素强烈影响 RYGB 对体重的影响。鉴定介导这种影响的特定基因将增进我们对 RYGB 后体重减轻的生物学机制的理解,并有助于确定最受益于这种干预的患者。